Loading stock data…
$1.32-0.06 (-4.35%)
OPKO Health, Inc.
OPKO Health, Inc. in the Healthcare sector is trading at $1.32 with a market capitalization of $985M. Wall Street consensus targets $4.38 (4 analysts), implying a +231.4% move over the next 12 months. The stock is currently 25% below its 52-week high of $1.75, remaining 0.8% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 5 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $163.58M↑ | $124.20M↓ | $148.45M↓ | $151.67M↓ | $156.81M |
| Gross Profit | $80.02M↑ | $45.76M↓ | $64.03M↑ | $49.89M↑ | $49.40M |
| Operating Income | -$25.04M↑ | -$51.02M↓ | -$38.32M↑ | -$53.52M↑ | -$59.98M |
| Net Income | -$8.42M↑ | -$54.85M↓ | -$31.26M↓ | $21.63M↑ | -$148.44M |
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a...